187 related articles for article (PubMed ID: 1944901)
41. Cyclophosphamide Treatment for Acquired Factor VIII Inhibitor in a Patient with AIDS-Associated Progressive Multifocal Leukoencephalopathy.
Malhotra U; Aboulafia DM
J Int Assoc Provid AIDS Care; 2016; 15(2):109-13. PubMed ID: 26013248
[TBL] [Abstract][Full Text] [Related]
42. Neuroepidemiology of acquired immunodeficiency syndrome.
Levy RM; Janssen RS; Bush TJ; Rosenblum ML
J Acquir Immune Defic Syndr (1988); 1988; 1(1):31-40. PubMed ID: 3216295
[TBL] [Abstract][Full Text] [Related]
43. Aids-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in São Paulo, Brazil.
Vidal JE; Penalva de Oliveira AC; Fink MC; Pannuti CS; Trujillo JR
Rev Inst Med Trop Sao Paulo; 2008; 50(4):209-12. PubMed ID: 18813759
[TBL] [Abstract][Full Text] [Related]
44. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
[TBL] [Abstract][Full Text] [Related]
45. AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures.
Moulignier A; Mikol J; Pialoux G; Fénelon G; Gray F; Thiebaut JB
Am J Med; 1995 Jul; 99(1):64-8. PubMed ID: 7598145
[TBL] [Abstract][Full Text] [Related]
46. Progressive multifocal leukoencephalopathy with gray matter involvement.
Ledoux S; Libman I; Robert F; Just N
Can J Neurol Sci; 1989 May; 16(2):200-2. PubMed ID: 2731089
[TBL] [Abstract][Full Text] [Related]
47. [Progressive multifocal leukoencephalopathy (PML) in AIDS: morphological and topographical characteristics].
Kuchelmeister K; Gullotta F; Bergmann M; Angeli G; Masini T
Verh Dtsch Ges Pathol; 1991; 75():189-90. PubMed ID: 1724829
[TBL] [Abstract][Full Text] [Related]
48. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
[TBL] [Abstract][Full Text] [Related]
49. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
[TBL] [Abstract][Full Text] [Related]
50. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
[TBL] [Abstract][Full Text] [Related]
51. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
52. Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases.
Kuchelmeister K; Gullotta F; Bergmann M; Angeli G; Masini T
Pathol Res Pract; 1993 Mar; 189(2):163-73. PubMed ID: 8321744
[TBL] [Abstract][Full Text] [Related]
53. HIV-associated PML: changing epidemiology and clinical approach.
Simpson DM
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S24-7. PubMed ID: 22123930
[TBL] [Abstract][Full Text] [Related]
54. Trends in the first ten years of AIDS in New York City. The New York City Department of Health AIDS Surveillance Team.
Thomas PA; Weisfuse IB; Greenberg AE; Bernard GA; Tytun A; Stellman SD
Am J Epidemiol; 1993 Jan; 137(2):121-33. PubMed ID: 8452116
[TBL] [Abstract][Full Text] [Related]
55. [The inefficacy of zidovudine (AZT) in progressive multifocal leukoencephalopathy (PML) associated with the acquired immunodeficiency syndrome (AIDS)].
Garrote FJ; Molina JA; Lacambra C; Mollejo M; Madero S; del Ser T
Rev Clin Esp; 1990 Nov; 187(8):404-7. PubMed ID: 2091134
[TBL] [Abstract][Full Text] [Related]
56. HIV prevalence estimates and AIDS case projections for the United States: report based upon a workshop.
MMWR Recomm Rep; 1990 Nov; 39(RR-16):1-31. PubMed ID: 1979423
[TBL] [Abstract][Full Text] [Related]
57. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
58. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
No To Shinkei; 2007 Feb; 59(2):125-37. PubMed ID: 17315754
[TBL] [Abstract][Full Text] [Related]
59. Making inroads on PML.
Smart T
GMHC Treat Issues; 1996 May; 10(5):10-2. PubMed ID: 11363582
[TBL] [Abstract][Full Text] [Related]
60. Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy.
Monno L; Zimatore GB; Di Stefano M; Appice A; Livrea P; Angarano G
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):369-73. PubMed ID: 10449561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
